Skip to content

Dangerous Things

Request correction

Retailer / private label

Unclaimed

Dangerous Things is a Seattle-based retailer of implantable RFID, NFC, and related human-augmentation hardware.

Last updated August 25, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Dangerous Things is an American biohacking and human-augmentation hardware retailer based in Seattle, Washington. The company was formed in 2013 by Amal Graafstra after a crowdfunding campaign focused on making implantable radio-frequency identification technology available for personal experimentation. Its products are aimed at people interested in body modification, personal identification, access control, and experimental cybernetic interfaces. The company is best known for offering implantable NFC- and RFID-compatible transponders intended for placement under the skin. Its principal implant kits combine a sterile injector assembly preloaded with the transponder and basic consumables such as antiseptic wipes, gauze, a bandage, and gloves. The products are marketed as tools for users who want to interact with compatible readers or systems without carrying a conventional card, key fob, or other external token. Dangerous Things has also offered a transponder incorporating an LED that illuminates when the device is scanned, extending the concept from passive identification to a visible body-embedded interface. Dangerous Things emphasizes the experimental and non-medical nature of its products. The company states that its implant kits have not been certified by a government regulatory agency for implantation or use inside the human body and warns customers that use is at their own risk. This positioning distinguishes the business from conventional medical-device manufacturers and places responsibility for informed use, implantation, and aftercare outside the scope of a standard clinical product offering. The catalog has also included supporting items such as numbing gel, pain-management supplies, large-gauge needles, and scalpels. In September 2020, Dangerous Things launched another crowdfunding campaign for the Titan, described as a titanium-encased, fully biocompatible sensing magnet. The project broadened the company’s focus beyond identification transponders toward implanted sensing and interaction hardware. The Titan campaign reflected the company’s continuing interest in developing products for the do-it-yourself biohacking community, where users explore technologies that connect the human body with digital systems. By January 2026, the company was also reported to offer a wearable ring with RFID capability, giving customers a non-implantable form of access to related functionality. The ring complements the company’s implant products and provides an option for users who want RFID interaction without an implanted device. Across its product range, Dangerous Things occupies a niche at the intersection of consumer electronics, body modification, RFID/NFC applications, and experimental biohacking. Publicly available reference material provides limited information about its corporate structure, revenue, ownership, international distribution, and executive team beyond its founder.

History

Dangerous Things emerged in 2013 from the work of Amal Graafstra and a crowdfunding effort intended to make implantable identification technology accessible to individual users. Rather than operating as a conventional medical-device company, the business developed a retail and experimental model centered on cybernetic microchip implants and related body-augmentation equipment. Its Seattle base places it within the broader technology and maker ecosystem associated with personal electronics, open experimentation, and do-it-yourself hardware. The company’s early and most recognizable offering was an implantable transponder compatible with NFC and RFID systems. Dangerous Things packaged the transponder in a kit containing a sterile injector assembly and basic preparation and wound-care supplies. The format was designed for customers seeking a ready-to-use product for personal implantation, although the company explicitly cautioned that the kit had not been certified by a government regulatory agency for implantation or use inside the human body. It also described use as being at the customer’s own risk. These warnings are central to the company’s identity: its products are presented as experimental consumer hardware rather than approved medical treatments or ordinary clinical devices. The implantable transponders were intended to allow users to interact with compatible readers and systems through a device placed beneath the skin. In practical terms, this could support identification, access, or other RFID/NFC applications. Dangerous Things also offered a version containing an LED that lights when the RFID chip is scanned. That design gave the normally invisible interaction a visible output and illustrated the company’s broader interest in turning the body into an interface for digital systems. Over time, the product range expanded beyond the core transponder. Related catalog items included numbing gel, pain-management supplies, large-gauge needles, and scalpels. These products supported the company’s niche as a source of equipment for individuals exploring implantation and body modification, although the available reference material does not establish the complete history, availability, or current status of every accessory. In September 2020, Dangerous Things began a crowdfunding campaign for the Titan. The project was described as a titanium-encased, fully biocompatible sensing magnet and represented a move from passive identification toward implanted sensing. The campaign continued the company’s focus on experimental devices that could create new forms of interaction between the human body and electronic systems. By January 2026, Dangerous Things was also reported to offer an RFID-capable wearable ring. This product extended the company’s technology into a non-implantable form, allowing users to engage with RFID functionality without undergoing implantation. The ring can therefore be understood as a complementary offering rather than a replacement for the company’s implant catalog. Public reference material identifies Dangerous Things as active and confirms its Seattle location, founder, product focus, and major crowdfunding activity. It does not provide reliable details about incorporation, ownership, revenue, employee count, regulatory approvals, international market structure, or a broader executive team. Those aspects remain undocumented in this dossier.

  • 2026

    RFID wearable ring reported in the product range

    [1]

    By January 2026, the company was reported to offer an RFID-capable wearable ring as a non-implantable product.

  • 2020

    Titan sensing magnet crowdfunding campaign

    [1]

    Dangerous Things began a crowdfunding campaign for the Titan, a titanium-encased sensing magnet described as fully biocompatible.

  • 2013

    Company formed after crowdfunding campaign

    [1]

    Dangerous Things was formed in the United States by Amal Graafstra following a crowdfunding campaign focused on personal implantable identification technology.

  • 2013

    Implantable NFC/RFID transponder made publicly available

    [1]

    The company produced and marketed an implantable NFC-compliant transponder for human RFID use, packaged with an injector and basic consumables.

Products and positioning

A specialist biohacking retailer providing experimental implantable and wearable RFID, NFC, and sensing technologies for personal identification, access, and human-computer interaction.

  • Implantable identification hardware · 2013

    Implantable RFID/NFC transponder kit

    Dangerous Things’ principal product category consists of implantable transponders compatible with NFC and RFID readers. The kits include a sterile injector assembly preloaded with the implant and basic supplies such as antiseptic wipes, gauze, a bandage, and gloves. The devices are intended for experimental personal identification, access, and digital-interface applications. The company warns that the kits are not certified by a government regulatory agency for implantation or use inside the human body.

  • Implantable interactive hardware

    LED implantable transponder

    This implant variant combines RFID functionality with an LED that illuminates when the chip is scanned. The visible signal makes an otherwise invisible RFID interaction perceptible to the user and demonstrates Dangerous Things’ interest in experimental body-based interfaces. It is positioned as an augmentation product rather than as a conventional medical device, and the company’s general warnings regarding implantation and personal risk apply.

  • Implantable sensing hardware · 2020

    Titan

    Titan is a sensing magnet project housed in a titanium casing. Dangerous Things described it as fully biocompatible and began a crowdfunding campaign for the product in September 2020. The device broadened the company’s focus from RFID-based identification toward implanted sensing and physical interaction with magnetic fields or objects. The available reference material does not establish the product’s full commercial status or technical specifications.

  • Wearable RFID hardware

    RFID wearable ring

    The RFID wearable ring provides a non-implantable way to use RFID functionality associated with the company’s product ecosystem. It offers an alternative for users who want a wearable form factor rather than a subdermal implant. The product was reported as part of the company’s offering by January 2026, but the available material does not specify its exact RFID standard, launch date, or distribution footprint.

  • Biohacking and implantation accessories

    Implant-support supplies

    Related products offered by Dangerous Things have included numbing gel, pain-management supplies, large-gauge needles, and scalpels. These items support the company’s broader retail focus on experimental implantation and body modification. The reference material does not establish whether every accessory remains available, nor does it provide details about brands, specifications, or regulatory status.

Marketing campaigns

  • 2020Titan crowdfunding campaign

    Not specified

    In September 2020, Dangerous Things began a crowdfunding campaign for the Titan, described as a titanium-encased fully biocompatible sensing magnet.

  • 2013Initial implantable transponder crowdfunding campaign

    United States

    A crowdfunding campaign preceded the formation of Dangerous Things and supported the development or public availability of personal implantable RFID/NFC technology.

    Outcome. The company was formed after the campaign and subsequently marketed implantable transponder kits.

Brand decisions

  • 2026

    Addition of a non-implantable RFID form factorStrategy

    Background

    The company’s reported product range expanded from implanted devices to a wearable option.

    Action taken

    Dangerous Things offered an RFID-capable wearable ring by January 2026.

    Aftermath

    The ring provided a non-implantable alternative within the company’s RFID-oriented product ecosystem.

  • 2020

    Development of the Titan sensing magnetProduct launch

    Background

    Dangerous Things sought to extend its product range beyond RFID identification toward implanted sensing technologies.

    Action taken

    The company began a crowdfunding campaign for a titanium-encased sensing magnet described as fully biocompatible.

  • 2013

    Launch of publicly available implantable RFID/NFC transponderProduct launch

    Background

    The company was created around making implantable identification technology available for individual experimentation.

    Action taken

    Dangerous Things marketed a transponder kit containing an implant, injector assembly, and basic preparation and wound-care supplies.

    Aftermath

    The product established the company’s position in the consumer biohacking and human-augmentation niche.

Sources1 sources

Cite this profile: Cite the canonical profile. /brand-wiki/dangerous-things · Editorial policy · How profiles are compiled